Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma. - Wikidata - wikimedia - TriplyDB

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

http://www.wikidata.org/entity/Q37035820

about

Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.Precision monitoring takes the stage Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma.Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.Minimal Residual Disease Assessment in Lymphoma: Methods and Applications.Minimal residual disease in non-Hodgkin lymphoma - current applications and future directions.Current prognostic and predictive factors in follicular lymphoma.New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies

P2860

Q30248407-D1CF3984-26B4-4834-9A6C-465C56C818D9 Q37097081-2CDA85CB-DA1D-4A54-8C8D-F11E8FE9E1A3 Q38853677-3803FAE4-F078-4F7A-86EB-61DC13CBFB88 Q38909384-5A0EA972-FF20-4FFE-8E96-B8227614FC8A Q38959472-FEA6C4AC-1F77-403D-9991-B349E7A0C4FE Q47568589-8A6E85B9-B14B-4349-8126-C3EA717E083A Q47873950-012EE0B6-E208-4C05-9E6A-67A497181ADE Q48185856-9949E92B-24CF-4499-96F7-08A1F57FB868 Q58723303-40804F70-CD82-4355-AD75-11963ECD3A89

P2860

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

http://www.wikidata.org/entity/Q37035820

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

@en

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

@nl

type

label

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

@en

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

@nl

prefLabel

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

@en

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.

@nl

P1433

Q37035820-3666AD2A-3D71-4EF2-A93F-BE7EA0A8E47E

P1476

Q37035820-B409F9EE-4DF6-46F2-9FD2-902483280667

P2093

Q37035820-1D03E8AF-ACEF-4CEE-80A9-FA5CC6BEA426

Q37035820-8AC72EBF-1F76-466C-A484-1C035B1CDA90

P2860

Q37035820-01669F8D-821A-4101-BBFA-526D01FA5B5F

Q37035820-039FB80E-2E2B-4E7D-B43C-F299CFC4942A

Q37035820-064217E7-CE8B-4CFB-9550-49C0A5231167

Q37035820-0EA61F55-EEB8-4B9D-BEA0-F767CCF8F72D

Q37035820-1C9F2A12-40A0-4119-B92E-A332749BDC57

Q37035820-2258CF5F-06E4-4410-ABB2-073B7268D9E0

Q37035820-280AC75C-0782-451A-B8CD-B524748B4DFA

Q37035820-2BD9E020-D5C2-4817-BD25-AEF604D3889B

Q37035820-44A87911-9A2F-41C0-9A2D-032BC2D8BF85

Q37035820-44B3CBB9-A052-4DED-AC95-F89885EEE87C

P304

Q37035820-463D1A70-DDED-46E7-8DF8-2EA5AEB4CAB0

P31

Q37035820-7C22DE25-F5AE-4505-8519-D63558F294BA

P356

Q37035820-BC6F7C78-4CDD-4C6F-BFDC-1DF134C085A3

P407

Q37035820-B524EDE5-6AD4-4107-903D-45B8CAB2D482

P433

Q37035820-BD268F36-23D2-4832-8B85-A43868CBD1DE

P478

Q37035820-58D706DB-D184-4B79-8DAC-A8581257AF92

P50

Q37035820-13F273C3-84F3-45D0-B904-229F1487901D

P577

Q37035820-40818ADA-1620-44EB-BEFB-A5C55524132E

P698

Q37035820-FBE0DED9-39BF-479C-9A79-E4E44E3E38B5

P932

Q37035820-3EAA0CD5-29C2-456C-A3EF-8C44A947B9E6

P356

BLOOD-2016-03-635219

P1433

P1476

Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma

@en

P2093

Louis M Staudt

http://www.w3.org/2001/XMLSchema#string

Wyndham H Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Computed Tomography — An Increasing Source of Radiation Exposure

Liquid biopsies: genotyping circulating tumor DNA

Toward understanding and exploiting tumor heterogeneity

Detection of circulating tumor DNA in early- and late-stage human malignancies

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Cell-free nucleic acids as biomarkers in cancer patients.

Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA.

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

P304

3127-3132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-03-635219

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Mark Roschewski

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27081097

http://www.w3.org/2001/XMLSchema#string

P932

4920019

http://www.w3.org/2001/XMLSchema#string